CBI probes CGHS officials, pharma firms over kickbacks
The story in brief
CBI registered a FIR against CGHS officials and pharma firms for alleged kickbacks. The case implicates Lorven Pharma and its proprietor, with officials accused of processing supply orders in exchange for illegal gratification. The FIR covers transactions between 2022 and 2025, with further investigations planned.